Case report of radiotherapy combined with anlotinib and immunotherapy for a patient with esophageal cancer and esophageal fistula

CONCLUSION: After radiation therapy, the patient continued to be treated with anlotinib and immunotherapy with camrelizumab, and the patient's lesion improved.PMID:38142544 | DOI:10.1016/j.apradiso.2023.111162

Source: Applied Radiation and Isotopes - December 24, 2023 Category: Radiology Authors: Lumei He Qian Han Mingming Zhao Haodong Ma Peng Cheng Hongjie Yang Yang Zhao Source Type: research